Pramipexole Dihydrochloride Tablets 0.125 mg recall: Subpotent
Pramipexole Dihydrochloride Tablets 0.125 mg,90-count bottle, Rx Only, Manufactured for: Macleods Pharma USA, Inc. Plainsboro, NJ 08536, Manufactured…
Why was Pramipexole Dihydrochloride Tablets 0.125 mg recalled?
Subpotent Drug: Out of specification result during stability study in Pramipexole Dihydrochloride Tablets 0.125 mg
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot #BPA801A, EXP 12/2020
- Product
- Pramipexole Dihydrochloride Tablets 0.125 mg,90-count bottle, Rx Only, Manufactured for: Macleods Pharma USA, Inc. Plainsboro, NJ 08536, Manufactured…
- Recalling firm
- Macleods Pharma Usa Inc
- Quantity
- 1837 90-count bottles
- Distribution
- Distributed Nationwide in the USA
- Recall date
- September 18, 2019
- Classification
- Class III
- Status
- Terminated
- Agency
- FDA (drug)